- RCKT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Rocket Pharmaceuticals (RCKT) CORRESPCorrespondence with SEC
Filed: 17 Feb 15, 12:00am
VIA EDGAR
February 17, 2015
United State Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4720
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jeffrey P. Riedler
Austin Stephenson
Re: | Inotek Pharmaceuticals Corporation (the “Company”) |
Registration Statement on Form S-1 File No. 333-199859 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), and as representatives of the several underwriters of the Company’s proposed public offering of shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”) and proposed offering of the Company’s convertible senior notes due 2020 (the “Convertible Notes”), we hereby join the Company’s request for acceleration of the effective date of the above-referenced Registration Statement, as amended, requesting effectiveness for 4:00 p.m. (ET) on February 17, 2015, or as soon thereafter as practicable.
Pursuant to Rule 460 of the Act, we wish to advise you that we have distributed approximately 1,415 copies of the Company’s preliminary prospectus relating to the Common Stock, dated January 21, 2015, and approximately 1,090 copies of the Company’s preliminary prospectus relating to the Convertible Notes, dated January 21, 2015, through the date hereof to underwriters, dealers, institutions and others.
The undersigned, as representatives of the several underwriters, have complied and will continue to comply, and have been informed by the participating underwriters that they have complied and will continue to comply, with the provisions of Rule 15c2-8 of the Securities Exchange Act of 1934, as amended.
[Signature page follows]
Very truly yours, | ||
COWENAND COMPANY, LLC PIPER JAFFRAY & CO. NOMURA SECURITIES INTERNATIONAL, INC. | ||
Acting on their own behalf and as representatives of several underwriters |
BY: COWENAND COMPANY, LLC | ||
By: | /s/ Grant Miller | |
Name: Grant Miller Title: Managing Director |
BY: PIPER JAFFRAY & CO. | ||
By: | /s/ Christie L. Christina | |
Name: Christie L. Christina Title: Managing Director |
By: NOMURA SECURITIES INTERNATIONAL, INC. | ||
By: | /s/ Arun Master | |
Name: Arun Master Title: Managing Director |